Biosplice Therapeutics

Description Developer of tissue-level therapeutic drugs intended to cure degenerative diseases in patients. The company discovers new targets and biological processes in the Wnt pathway, allowing them to develop small molecule drugs that potentially address numerous degenerative conditions as well as many forms of cancer.

Vertical Drug Discovery

http://www.biosplice.com
Founded 2008
Team Size 239
Headquarter United States